Next Article in Journal
The Mechanism and Latest Research Progress of Blood–Brain Barrier Breakthrough
Previous Article in Journal
ADHD and Risk of Precocious Puberty: Considering the Impact of MPH
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomedicines
Volume 12
Issue 10
10.3390/biomedicines12102305
biomedicines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Retraction of Biomedicines 2021, 9(8), 990.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

RETRACTED: El-Far et al. Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer. Biomedicines 2021, 9, 990

by
Ali H. El-Far
1,
Kavitha Godugu
2,
Taher A. Salaheldin
2,
Noureldien H. E. Darwish
2,
Amna A. Saddiq
3 and
Shaker A. Mousa
2,*
1
Department of Biochemistry, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt
2
Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA
3
Department of Biology, College of Sciences, University of Jeddah, Jeddah 21589, Saudi Arabia
*
Author to whom correspondence should be addressed.
Biomedicines 2024, 12(10), 2305; https://doi.org/10.3390/biomedicines12102305
Submission received: 6 August 2024 / Accepted: 25 September 2024 / Published: 10 October 2024
(This article belongs to the Section Nanomedicine and Nanobiology)
Versions Notes
The journal retracts the article, “Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer” [1], cited above.
Following publication, concerns were brought to the attention of the publisher regarding the reliability of the figures presented in this article [1].
Adhering to our complaint’s procedure, an investigation was conducted by the Editorial Office and Editorial Board, with input from the Albany College of Pharmacy and Health Sciences. During this process, the authors were unable to satisfactorily explain the similarities between Figure 6A,C nor provide raw material for the Editorial Board to review.
As a result, the Editorial Board has lost confidence in the reliability of the findings and decided to retract this publication [1] in agreement with the recommendations of the Albany College of Pharmacy and Health Sciences and as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30, accessed on 8 August 2024).
This retraction was approved by the Editor-in-Chief of the journal Biomedicines.
The authors did not agree to this retraction.

Reference

  1. El-Far, A.H.; Godugu, K.; Salaheldin, T.A.; Darwish, N.H.E.; Saddiq, A.A.; Mousa, S.A. RETRACTED: Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer. Biomedicines 2021, 9, 990. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

El-Far, A.H.; Godugu, K.; Salaheldin, T.A.; Darwish, N.H.E.; Saddiq, A.A.; Mousa, S.A. RETRACTED: El-Far et al. Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer. Biomedicines 2021, 9, 990. Biomedicines 2024, 12, 2305. https://doi.org/10.3390/biomedicines12102305

AMA Style

El-Far AH, Godugu K, Salaheldin TA, Darwish NHE, Saddiq AA, Mousa SA. RETRACTED: El-Far et al. Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer. Biomedicines 2021, 9, 990. Biomedicines. 2024; 12(10):2305. https://doi.org/10.3390/biomedicines12102305

Chicago/Turabian Style

El-Far, Ali H., Kavitha Godugu, Taher A. Salaheldin, Noureldien H. E. Darwish, Amna A. Saddiq, and Shaker A. Mousa. 2024. "RETRACTED: El-Far et al. Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer. Biomedicines 2021, 9, 990" Biomedicines 12, no. 10: 2305. https://doi.org/10.3390/biomedicines12102305

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop